These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9069483)
1. Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings. Richards M; Meade TW; Peart S; Brennan PJ; Mann AH J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):269-72. PubMed ID: 9069483 [TBL] [Abstract][Full Text] [Related]
2. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092 [TBL] [Abstract][Full Text] [Related]
3. Antithrombotic treatment and the incidence of angina pectoris. Knottenbelt C; Brennan PJ; Meade TW; Arch Intern Med; 2002 Apr; 162(8):881-6. PubMed ID: 11966338 [TBL] [Abstract][Full Text] [Related]
4. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237 [TBL] [Abstract][Full Text] [Related]
5. Thrombosis prevention trial: follow-up study of practical implications. Fasey N; Brennan PJ; Meade TW; Br J Gen Pract; 2002 Mar; 52(476):208-9. PubMed ID: 12030663 [TBL] [Abstract][Full Text] [Related]
6. Low dose aspirin and cognitive function in the women's health study cognitive cohort. Kang JH; Cook N; Manson J; Buring JE; Grodstein F BMJ; 2007 May; 334(7601):987. PubMed ID: 17468120 [TBL] [Abstract][Full Text] [Related]
7. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design. Pullicino P; Thompson JL; Barton B; Levin B; Graham S; Freudenberger RS; J Card Fail; 2006 Feb; 12(1):39-46. PubMed ID: 16500579 [TBL] [Abstract][Full Text] [Related]
8. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy. Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425 [TBL] [Abstract][Full Text] [Related]
9. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement. Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279 [TBL] [Abstract][Full Text] [Related]
10. Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect. Rudnicka AR; Ashby D; Brennan P; Meade T Arch Intern Med; 2003 Jun; 163(12):1454-60. PubMed ID: 12824095 [TBL] [Abstract][Full Text] [Related]
11. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P; N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192 [TBL] [Abstract][Full Text] [Related]
12. Warfarin and aspirin for prevention of IHD. Zamorski MA J Fam Pract; 1998 May; 46(5):358-9. PubMed ID: 9597990 [No Abstract] [Full Text] [Related]
13. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Sacco RL; Prabhakaran S; Thompson JL; Murphy A; Sciacca RR; Levin B; Mohr JP; Cerebrovasc Dis; 2006; 22(1):4-12. PubMed ID: 16567931 [TBL] [Abstract][Full Text] [Related]